Karen Stolman, MD
Dermatology · Park City, UTNPI 1700997699
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 21 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Galderma Laboratories, L.p. at 37.3% of the total. Reporting peaked in 2023 at $565 and has fallen 62.1% since, to $214 in 2025. That places this record below the midpoint for dermatology clinicians in UT, where the typical reported total is $1,056.
Across 21 payments — averaging $57.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$450
- Merz North America, Inc.$283
- AbbVie$139
- Incyte Corporation$135
- Dermavant Sciences, Inc.$84
- Revance Therapeutics, Inc.$61
- plus $54 from 2 others
What the payments were for
- Food & beverage$1,206100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 6 | $450 |
| Merz North America, Inc. | 5 | $283 |
| AbbVie(2 entities) | 4 | $139 |
| Incyte Corporation | 1 | $135 |
| Dermavant Sciences, Inc. | 1 | $84 |
| Revance Therapeutics, Inc. | 1 | $61 |
| Arcutis Biotherapeutics, Inc. | 2 | $30 |
| Pfizer | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,206 in reported general payments places this provider in the 50th percentile of 163 dermatology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 12 | $347 |
| Triamcinolone Acetonide | 21 | $218 |
| Ketoconazole | 15 | $211 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Park City
- Brian WilliamsMidvale$876K
- Travis JamesProvidence$437K
- Jason HadleyBountiful$294K
- Doug Lass ForshaWest Jordan$213K
- Gerald KruegerSalt Lake City$156K
- Jamie RhoadsMurray$105K
- Kristina DuffinSalt Lake City$89K
- Mark TaylorSalt Lake City$58K
- Lori RamirezKaysville$38K
- Sancy LeachmanMurray$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.